Clinical Trial Update: Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) [Phase 2]

View source ↗

Summary

Phase 2 trial AdeLE evaluating Lymfactin for secondary lymphedema has completed; the study was sponsored by Herantis Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphedema

Drugs mentioned

• Lymfactin

Snippet

Sponsor: Herantis Pharma Plc. | Conditions: Secondary Lymphedema | Phase 2 | Status: COMPLETED